Publications by authors named "Joyce Doorn"

Claim this Profile
A
At-home blood collection for clinical chemistry analyses in a kidney transplant population: a feasibility study.
Jorrit Hoekstra, Manon Wilpshaar, Stefan Berger, Joyce Doorn

Clin Chem Lab Med· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kidney Function in Patients With Neuromuscular Disease: Creatinine Versus Cystatin C.
Elles M Screever, Jenny E Kootstra-Ros, Joyce Doorn, Jellie A Nieuwenhuis, Henk E J Meulenbelt

Front Neurol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin-like growth factor-I enhances proliferation and differentiation of human mesenchymal stromal cells in vitro.
Joyce Doorn, Scott J Roberts, Janneke Hilderink, Nathalie Groen, Aart van Apeldoorn

Tissue Eng Part A· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A small molecule approach to engineering vascularized tissue.
Joyce Doorn, Hugo A M Fernandes, Bach Q Le, Jeroen van de Peppel, Johannes P T M van Leeuwen

Biomaterials· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diverse effects of cyclic AMP variants on osteogenic and adipogenic differentiation of human mesenchymal stromal cells.
Joyce Doorn, Maarten Leusink, Nathalie Groen, Jeroen van de Peppel, Johannes P T M van Leeuwen

Tissue Eng Part A· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic applications of mesenchymal stromal cells: paracrine effects and potential improvements.
Joyce Doorn, Guido Moll, Katarina Le Blanc, Clemens van Blitterswijk, Jan de Boer

Tissue Eng Part B Rev· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Forskolin enhances in vivo bone formation by human mesenchymal stromal cells.
Joyce Doorn, Ramakrishnaiah Siddappa, Clemens A van Blitterswijk, Jan de Boer

Tissue Eng Part A· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-osteogenic trophic effects by PKA activation in human mesenchymal stromal cells.
Joyce Doorn, Jeroen van de Peppel, Johannes P T M van Leeuwen, Nathalie Groen, Clemens A van Blitterswijk

Biomaterials· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing, rather than the concentration of cyclic AMP, correlates to osteogenic differentiation of human mesenchymal stem cells.
Ramakrishnaiah Siddappa, Joyce Doorn, Jun Liu, Eli Langerwerf, Roel Arends

J Tissue Eng Regen Med· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
Maarten van Dinther, Nils Visser, David J J de Gorter, Joyce Doorn, Marie-José Goumans

J Bone Miner Res· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivo.
Ramakrishnaiah Siddappa, Anton Martens, Joyce Doorn, Anouk Leusink, Cristina Olivo

Proc Natl Acad Sci U S A· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis